Literature DB >> 8189810

[Etiology of bacterial endocarditis in materials from Cardiology and Cardiac Surgery Clinics of the Lodz Academy].

B Dudkiewicz1, E Szewczyk.   

Abstract

In the years 1986-1991, 72 cases of bacterial endocarditis (BE) were investigated. The bacteria were isolated from blood in 24 cases, from native and artificial valves obtained during surgery in 24 cases, and from both blood and valves in 6 cases. Following microorganisms were isolated: S. epidermidis, S. xylosus, S. hominis, S. aureus, Micrococcus sp., S. mitis, S. sanguis, S. faecalis, M. lacunata, E. adecarboxylata, P. maltophila, Corynebacterium sp., A. calcoaceticus var. lwoffii, and Aspergillus sp. Gram-positive bacteria were prevailing among isolated strains. Staphylococci were present in 55.7% (29 cases) and among them coagulase-negative staphylococci occurred in 89.7% (26 cases). Streptococci were isolated from 9 patients (17.3%) and Gram-negative rods from 5 patients (9.65%). Coryneform bacteria were detected in 7 cases (13.5%). There was no relation between type of removed valve and colonizing it bacteria. From native and artificial valves coagulase-negative staphylococci were isolated, respectively, in 48.3% and 52.2%. Susceptibility of isolated bacteria to 27 antibiotics was determined. Multiple resistant strains were present most frequently among staphylococci.

Entities:  

Mesh:

Year:  1993        PMID: 8189810

Source DB:  PubMed          Journal:  Med Dosw Mikrobiol        ISSN: 0025-8601


  2 in total

1.  The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.

Authors:  Agnieszka Bera; Raja Biswas; Silvia Herbert; Friedrich Götz
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

2.  Isolations of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus.

Authors:  T de Baere; G Wauters; A Huylenbroeck; G Claeys; R Peleman; G Verschraegen; D Allemeersch; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.